I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Retina Society 2020

-
Coming soon
09:00 AM
Duration 6mins Virtual
Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure Optimization and Use of Virtual Reality (VR) Simulators in PDS Trials
Miller, D, Gune S, Barteselli G

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 6mins Virtual
What Happens to Diabetic Retinopathy Severity With Less Frequent Ranibizumab Treatment? A Post Hoc Analysis of the RISE/RIDE Open-Label Extension Study
Goldberg R, Hill L, Abolian A, Stoilov I

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:00 PM
Duration 6mins Virtual
Key Learnings from the Phase 2 Ladder Trial of the Port Delivery System with Ranibizumab (PDS) in Patients with Neovascular AMD
Eichenbaum D, Blotner S, Barteselli G, Gune S

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:00 PM
Duration 6mins Virtual
Effect of Dual Angiopoietin-2/VEGF-A Inhibition with Faricimab on Macular Anatomy in the STAIRWAY Phase 2 Study of Neovascular Age-Related Macular Degeneration
Lad E, Lin H, Silverman D, Basu, K, Quezada C, Haskova Z

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 6mins Virtual
Macular Atrophy (MA) in the Phase 2 Ladder Trial
Jaffe G, Barteselli G, Lin C-Y, Gune S

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 6mins Virtual
Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 2 Ladder Trial
Pieramici D, Gune S, Maass K, Maia M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:00 PM
Duration 6mins Virtual
Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD (nAMD)
Awh C, Singh N, Kaufman D, Kardatzke D, Patel S, Gune S, Barteselli G

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar